PolyMASC Pharmaceuticals will be valued at around pounds 20m when it comes to the Alternative Investment Market. The company is to raise roughly pounds 5m from an offer of about 25 per cent of its shares. The main products are polymer coatings used for existing drugs.
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments